 |
|
|
| |
Analysis of Sustained Viral Response and Boceprevir Resistance Following Combination Treatment With Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in HCV Genotype 1 Prior Relapsers And Nonresponders
|
| |
| |
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
J Howe1, R Ogert1, R Barnard1, D Hazuda1, LD Pedicone1, CA Brass1, JK Albrecht1, and S Flamm2
1Merck, Sharp & Dohme Corp., Whitehouse Station, NJ; 2Northwestern Feinberg School of Medicine, Chicago, IL
|
| |
|
|
|
|
|
